Bart C.J.M. Fauser, M.D., Basil C. Tarlatzis, M.D., Robert W. Rebar, M.D., Richard S. Legro, M.D., Adam H. Balen, M.D., Roger Lobo, M.D., Enrico Carmina, M.D., Jeffrey Chang, M.D., Bulent O. Yildiz, M.D., Joop S.E. Laven, M.D., Jacky Boivin, M.D., Felice Petraglia, M.D., C.N. Wijeyeratne, M.D., Robert J. Norman, M.D., Andrea Dunaif, M.D., Stephen Franks, M.D., Robert A. Wild, M.D., Daniel Dumesic, M.D., Kurt Barnhart, M.D.
Volume 97, Issue 1 , Pages 28-38.e25
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with a high prevalence. The etiology of this heterogeneous condition remains obscure, and its phenotype expression varies. Two widely cited previous ESHRE/ASRM sponsored PCOS consensus workshops focused on diagnosis (published in 2004) and infertility management (published in 2008), respectively. The present third PCOS consensus report summarizes current knowledge and identifies knowledge gaps regarding various women’s health aspects of PCOS. Relevant topics addressed—all dealt with in a systematic fashion—include adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, pregnancy complications, long-term metabolic and cardiovascular health, and finally cancer risk. Additional, comprehensive background information is provided separately in an extended online publication.
Read the full text at: http://www.fertstert.org/article/S0015-0282(11)02552-0/fulltext